- 品名： 重組Anti-CD276抗體[EPNCIR122] (ab134161)
- 型號(hào)： ab134161
- 產(chǎn)品詳情
- 規(guī)格參數(shù)
描述
兔單克隆抗體[EPNCIR122] to CD276
宿主
Rabbit
經(jīng)測試應(yīng)用
適用于: IHC-Fr, WB, IP, Flow Cyt, ICC/IFmore details
不適用于: IHC-P種屬反應(yīng)性
與反應(yīng): Mouse, Human, Recombinant fragment
免疫原
Recombinant full length protein corresponding to Human CD276. Alternate injections with Human recombinant protein and Human CD276 over-expressing CHO cells.
Database link: Q5ZPR3
(Peptide available asab182198) 陽性對(duì)照
WB: LnCaP, CHO-K1 cells lysates transfected with human and mouse CD276. Flow Cyt: HEK293 and THP1 cells. ICC/IF: HEK293 cells.
常規(guī)說明
This antibody was developed as part of a collaboration between Epitomics, the National Cancer Institute's Center for Cancer Research and the lab of Brad St. Croix.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information see here.
Our RabMAb? technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb? patents.
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free production
